Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment

Clinical trial NCT01298323 · COMPLETED

Trial details

NCT number

NCT01298323

Sponsor

Sanofi

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2011-02-25

Primary completion

2013-04-26

Enrollment

205

View on ClinicalTrials.gov